Publications:

Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer.

World Journal Of Gastrointestinal Oncology

Valenzuela, Guillermo G; Burotto, Mauricio M; Marcelain, Katherine K; González-Montero, Jaime J

Publication Date: 2022-09-15

Variant appearance in text: HER2: R784G

PubMed Link: 36187383

Variant Present in the following documents:

• WJGO-14-1654.pdf

View BVdb publication page

Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment.

Cancers

Marin, Jose J G JJG; Macias, Rocio I R RIR; Monte, Maria J MJ; Herraez, Elisa E; Peleteiro-Vigil, Ana A; Blas, Beatriz Sanchez de BS; Sanchon-Sanchez, Paula P; Temprano, Alvaro G AG; Espinosa-Escudero, Ricardo A RA; Lozano, Elisa E; Briz, Oscar O; Romero, Marta R MR

Publication Date: 2020-09-11

Variant appearance in text: ERBB2: R784G

PubMed Link: 32933095

Variant Present in the following documents:

• Main text
• cancers-12-02605.pdf

View BVdb publication page

The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab.

Biomolecules

Shin, Jung Won JW; Kim, Soohyun S; Ha, Suji S; Choi, Byungsan B; Kim, Seongyeong S; Im, Seock-Ah SA; Yoon, Tae-Young TY; Chung, Junho J

Publication Date: 2019-10-19

Variant appearance in text: HER2: R784G

PubMed Link: 31635022

Variant Present in the following documents:

• biomolecules-09-00629.pdf

View BVdb publication page